News
Dupixent shows potential as a treatment for atopic dermatitis, alopecia and vitiligo, targeting shared immune pathways for ...
Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.
9h
TipRanks on MSNPfizer’s Phase 3 Study on Abrocitinib: A Potential Game-Changer for Atopic Dermatitis Treatment
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3 study titled ‘A Phase 3 Multi-Center, ...
Long-term exposure to pollutants was linked to higher psoriasis risk, especially in people with genetic predispositions.
The vitiligo treatment landscape is evolving with a shift towards targeted therapies, which have shown encouraging results in promoting repigmentatio ...
Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect, or the Company) and the Jovante Woods Foundation (the Foundation) today kicked off a collaboration to expand the ...
9h
TipRanks on MSNPfizer’s Latest Clinical Study on Abrocitinib for Pediatric Eczema: Key Insights for Investors
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study titled A 16-WEEK, MULTICENTER, ...
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Aug. 14, 2025 /PRNewswire/ -- U ...
Veterinary school warns of severe feline illness following ingestion of oclacitinib chewable tablets
Two cats who ingested the dog allergy medication experienced acute kidney injury and required 4 rounds of hemodialysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results